MoreBack to News Headlines


Judge conditionally approves Purdue Pharma opioid settlement, shielding Sackler family from future lawsuits
CBSN
A federal bankruptcy judge on Wednesday gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades.
Under the settlement reached with creditors including individual victims and thousands of state and local governments, the Sackler family will give up ownership of the company and contribute $4.5 billion but will be freed from any future lawsuits over opioids. The drugmaker will be reorganized into a new company with a board appointed by public officials and will funnel its profits into government-led efforts to prevent and treat opioid addiction.More Related News

Colleges are slightly less diverse as admissions officers seek ways to adapt post-affirmative action
The full impact of the Supreme Court's June 2023 ruling that colleges can't consider race in admissions may not be known for years. But a CBS News analysis of enrollment records shows the first class of freshmen since the high court's order is a little less diverse than the class before it.